Skip to Content

Incruse Ellipta Side Effects

Generic Name: umeclidinium

Note: This page contains information about the side effects of umeclidinium. Some of the dosage forms included on this document may not apply to the brand name Incruse Ellipta.

For the Consumer

Applies to umeclidinium: inhalation powder

In addition to its needed effects, some unwanted effects may be caused by umeclidinium (the active ingredient contained in Incruse Ellipta). In the event that any of these side effects do occur, they may require medical attention.

Major Side Effects

You should check with your doctor immediately if any of these side effects occur when taking umeclidinium:

Less common:
  • Bladder pain
  • bloody or cloudy urine
  • cough or hoarseness
  • difficulty with breathing
  • fainting
  • fast, pounding, or irregular heartbeat or pulse
  • fever or chills
  • loss of voice
  • lower back or side pain
  • painful or difficult urination
  • sore throat
  • unusual tiredness or weakness
Incidence not known:
  • Blurred vision
  • decreased urination
  • difficulty in passing urine (dribbling)
  • eye pain or discomfort

Minor Side Effects

Some of the side effects that can occur with umeclidinium may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional:

Less common:
  • Acid or sour stomach
  • body aches or pain
  • depression
  • diarrhea
  • dizziness or lightheadedness
  • joint pain
  • nausea
  • rash
  • sensation of spinning
  • upper abdominal or stomach pain

For Healthcare Professionals

Applies to umeclidinium: inhalation powder

Cardiovascular

Common (1% to 10%): Tachycardia, hypertension, sinus tachycardia (greater than or equal to 1%)
Uncommon (0.1% to 1%): Atrial fibrillation, idioventricular rhythm, supraventricular tachycardia, supraventricular extrasystoles[Ref]

Dermatologic

Common (1% to 10%): Rash[Ref]

Gastrointestinal

Common (1% to 10%): Upper abdominal pain, toothache, dyspepsia (greater or equal to 1%), diarrhea (greater or equal to 1%), nausea (greater or equal to 1%)
Uncommon (0.1% to 1%): Constipation, dry mouth[Ref]

Genitourinary

Common (1% to 10%): Urinary tract infection
Frequency not reported: Worsening of urinary retention[Ref]

Musculoskeletal

Common (1% to 10%): Arthralgia, myalgia, back pain, neck pain (greater or equal to 1%), pain in extremity (greater or equal to 1%)[Ref]

Nervous system

Common (1% to 10%): Headache, sinus headache (greater or equal to 1%), dizziness (greater or equal to 1%)
Uncommon (0.1% to 1%): Dysgeusia[Ref]

Other

Common (1% to 10%): Contusion, vertigo (greater or equal to 1%)[Ref]

Psychiatric

Common (1% to 10%): Depression (greater or equal to 1%)[Ref]

Respiratory

Common (1% to 10%): Nasopharyngitis, upper respiratory tract infection, viral respiratory tract infection, cough, sinusitis, pneumonia (greater than or equal to 1%), lower respiratory tract infection (greater than or equal to 1%), rhinitis (greater than or equal to 1%), oropharyngeal pain (greater than or equal to 1%)
Uncommon (0.1% to 1%): Pharyngitis[Ref]

Ocular

Frequency not reported: Worsening of narrow-angle glaucoma (eye pain or discomfort, blurred vision, visual halos or colored images in association with red eyes from conjunctival congestion and corneal edema)[Ref]

References

1. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

2. Cerner Multum, Inc. "Australian Product Information." O 0

3. "Product Information. Incruse Ellipta (umeclidinium)." GlaxoSmithKline, Research Triangle Park, NC.

Not all side effects for Incruse Ellipta may be reported. You should always consult a doctor or healthcare professional for medical advice. Side effects can be reported to the FDA here.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate safety, effectiveness, or appropriateness for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of materials provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the substances you are taking, check with your doctor, nurse, or pharmacist.

Hide